Search

Your search keyword '"Arnold S. Lippa"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Arnold S. Lippa" Remove constraint Author: "Arnold S. Lippa" Topic animals Remove constraint Topic: animals
48 results on '"Arnold S. Lippa"'

Search Results

1. GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors

2. Tarps differentially affect the pharmacology of ampakines

Catalog

Books, media, physical & digital resources

3. Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brain

4. Brain Vacuolation Resulting From Administration of the Type II Ampakine CX717 Is An Artifact Related to Molecular Structure and Chemical Reaction With Tissue Fixative Agents

5. Acute ampakine treatment ameliorates age-related deficits in long-term potentiation

6. Characterization of the Antinociceptive Actions of Bicifadine in Models of Acute, Persistent, and Chronic Pain

7. The Anxioselective Agent 7-(2-Chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) Is More Efficacious Than Diazepam at Enhancing GABA-Gated Currents at α1 Subunit-Containing GABAA Receptors

8. Selective anxiolysis produced by ocinaplon, a GABA A receptor modulator

9. Anxioselective anxiolytics: can less be more?

10. 'Broad spectrum' antidepressants: Is more better for the treatment of depression?

11. Antidepressant-like actions of DOV 21,947: a 'triple' reuptake inhibitor

12. Preclinical and clinical pharmacology of DOV 216,303, a 'triple' reuptake inhibitor

13. Pharmacological profile of the 'triple' monoamine neurotransmitter uptake inhibitor, DOV 102,677

14. Animal Tests of Anxiety

15. Clinical development of citalopram

16. Assay of Brain Calmodulin Levels Using High-Performance Liquid Chromatography

17. Benzodiazepine receptors: Cellular and behavioral characteristics

18. A synthetic non-benzodiazepine ligand for benzodiazepine receptors: A probe for investigating neuronal substrates of anxiety

19. Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors

20. The effects of acute administration of diazepam on the binding of [3H]-diazepam and [3H]-GABA to rat cortical membranes

21. Lateral olfactory tract lesions reveal neuronal localization of benzodiazepine recognition sites

22. The separation of 3H-Benzodiazepine binding sites in brain and of benzodiazepine pharmacological properties

23. Heterogeneity of brain benzodiazepine receptors: Effects of physiological conditions

24. AL721, a novel membrane fluidizer

25. Effects of clozapine, chlorpromazine and diazepam upon adjunctive and schedule controlled behaviors

26. Additional studies on the importance of glycine and GABA in mediating the actions of benzodiazepines

28. Dopamine receptor alterations with aging in mouse and rat corpus striatum

29. Desensitization of muscarinic acetylcholine receptors: possible relation to receptor heterogeneity and phosphoinositides

30. Chronic administration of cholinergic agents: effects on behavior and calmodulin

31. Endocrine factors contributing to the ethanol preferences of rodents

32. Evidence that benzodiazepine receptors reside on cerebellar purkinje cells: studies with 'nervous' mutant mice

33. Reduction of motor behavioral deficits in senescent animals via chronic prolactin administration. II. Non-stereotypic behaviors

34. Brain cholinergic dysfunction and memory in aged rats

35. The cholinergic hypothesis of geriatric memory dysfunction

36. Conformational changes in muscarinic receptors may produce diminished cholinergic neurotransmission and memory deficits in aged rats

37. Antagonism of the anxiolytic action of diazepam and chlordiazepoxide by the novel imidazopyridines, EMD 39593 and EMD 41717

38. Molecular substrates of anxiety: clues from the heterogeneity of benzodiazepine receptors

39. Relationship between benzodiazepine receptors and experimental anxiety in rats

40. Hippocampal muscarinic receptor loss following trimethyl tin administration

41. Reduction of motor behavioral deficits in senescent animals via chronic prolactin administration. I. Rotational behavior

42. Effect of AL 721, a novel membrane fluidizer, on the binding parameters of brain dopamine receptors

43. Enhancement of 3H-diazepam binding by SQ 65,396: a novel anti-anxiety agent

44. Norepinephrine stimulation of phospholipid methylation in rat cortical synaptosomes: fact or artifact?

45. Bimodal distributions of highest ethanol acceptance concentrations in two strains of rats

46. Effect of acute and chronic pentylenetetrazol treatment on benzodiazepine and cholinergic receptor binding in rat brain

47. Age-related alterations in neurotransmitter receptors: an electrophysiological and biochemical analysis

48. Neurochemical mediation of reward: a significant role for dopamine?